HomeCannabisCanopy Growth raising funds after discontinuing sports drink brand

Canopy Growth raising funds after discontinuing sports drink brand

In a bid to bolster its financial standing, Canopy Growth (TSX:WEED), the prolific North American cannabis and consumer packaged goods firm, has initiated a private placement transaction with institutional investors, potentially amounting to US$50 million.

This strategic move comes with an over-allotment option, permitting investors to acquire additional units at a given rate until 2 November 2023.

The capital garnered from this venture is earmarked for fortifying the company’s working capital and addressing other corporate exigencies.

The recent announcement notes the sale of nearly 22.9 million units, each priced at US$1.09, which encapsulates one common share of WEED and a purchase warrant that grants the holder the ability to acquire an additional share at US$1.35 within a five-year timeframe.

This deal, excluding the over-allotment option, is slated to conclude by 19 September 2023.

This development is aligned with Canopy Growth’s sustained positive trajectory, marked by significant debt reduction and a spate of business consolidations and divestments.

Notably, the firm recently distanced itself from its financially draining sports drink sector, BioSteel Sports Nutrition, as part of a cost-cutting measure to alleviate debts and enhance profitability.

The discontinuation of BioSteel, which witnessed a substantial contribution to Canopy’s Q1 losses this year, is anticipated to mitigate the company’s debts by around CN$95 million (£57m) in the forthcoming quarters.

Furthermore, amidst these reshaping strategies, the company’s stock has exhibited a buoyant trend, escalating by over 250% since its lowest point in July 2023.

Canopy Growth, home to renowned brands like Tweed and Martha Stewart CBD, is poised to further capitalise on the prospective legalisation of cannabis in the US, harnessing its ties with various prominent entities in the sector.

In light of the company relinquishing its BioSteel arm, it has cut ties with 181 employees. Despite facing challenges, major shareholder Constellation Brands retains its belief in Canopy Growth’s long-term potential, albeit with diminished direct involvement in the firm’s board decisions and transactions.

This comes as part of a broader effort to streamline operations and focus on core business strengths, pivoting towards a more profitable future.


Related Articles